BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sigdel TK, Archila FA, Constantin T, Prins SA, Liberto J, Damm I, Towfighi P, Navarro S, Kirkizlar E, Demko ZP, Ryan A, Sigurjonsson S, Sarwal RD, Hseish SC, Chan-On C, Zimmermann B, Billings PR, Moshkevich S, Sarwal MM. Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR. J Clin Med. 2018;8. [PMID: 30583588 DOI: 10.3390/jcm8010019] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Qazi Y, Patel A, Fajardo M, McCormick S, Fehringer G, Ahmed E, Malhotra M, Demko ZP, Billings PR, Tabriziani H, Gauthier P. Incorporation of Donor-derived Cell-free DNA Into Clinical Practice for Renal Allograft Management. Transplant Proc 2021:S0041-1345(21)00710-7. [PMID: 34774309 DOI: 10.1016/j.transproceed.2021.09.027] [Reference Citation Analysis]
2 Kumar N, Rana R, Rana DS, Gupta A, Sachdeva MP. Donor-Derived Cell-Free DNA to Diagnose Graft Rejection Post-Transplant: Past, Present and Future. Transplantology 2021;2:348-61. [DOI: 10.3390/transplantology2030034] [Reference Citation Analysis]
3 El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, Choi J, Allos H, Yatim K, Alhaddad J, Eskandari S, Chu P, Mihali AB, Lape IT, Lima Filho MP, Aoyama BT, Chandraker A, Safa K, Markmann JF, Riella LV, Formica RN, Skog J, Azzi JR. Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J Am Soc Nephrol 2021:ASN. [PMID: 33658284 DOI: 10.1681/ASN.2020060850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Filippone EJ, Gulati R, Farber JL. Noninvasive Assessment of the Alloimmune Response in Kidney Transplantation. Adv Chronic Kidney Dis 2021;28:548-60. [PMID: 35367023 DOI: 10.1053/j.ackd.2021.08.002] [Reference Citation Analysis]
5 Westphal SG, Mannon RB. Emerging biomarkers in kidney transplantation and challenge of clinical implementation. Curr Opin Organ Transplant 2022;27:15-21. [PMID: 34939960 DOI: 10.1097/MOT.0000000000000941] [Reference Citation Analysis]
6 Puliyanda DP, Swinford R, Pizzo H, Garrison J, De Golovine AM, Jordan SC. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants. Pediatr Transplant 2021;25:e13850. [PMID: 33217125 DOI: 10.1111/petr.13850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Park SH, Friedewald JJ. Are borderline changes real rejection? Current viewpoints. Curr Opin Nephrol Hypertens 2020;29:656-62. [PMID: 32889982 DOI: 10.1097/MNH.0000000000000648] [Reference Citation Analysis]
8 Altuğ Y, Liang N, Ram R, Ravi H, Ahmed E, Brevnov M, Swenerton RK, Zimmermann B, Malhotra M, Demko ZP, Billings PR, Ryan A. Analytical Validation of a Single-nucleotide Polymorphism-based Donor-derived Cell-free DNA Assay for Detecting Rejection in Kidney Transplant Patients. Transplantation 2019;103:2657-65. [PMID: 30801536 DOI: 10.1097/TP.0000000000002665] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
9 Altuğ Y, Demko ZP, Ryan A. The Author's Reply to "Performance of Donor-Derived Cell-Free DNA Assays in Kidney Transplant Patients". Transplantation 2020;104:e136-7. [PMID: 32317616 DOI: 10.1097/TP.0000000000003085] [Reference Citation Analysis]
10 Reddy T, Esmail A, Chang JC, Ghobrial RM, Abdelrahim M. Utility of Cell-Free DNA Detection in Transplant Oncology. Cancers (Basel) 2022;14:743. [PMID: 35159010 DOI: 10.3390/cancers14030743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM. Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies. Front Med (Lausanne) 2019;6:213. [PMID: 31632976 DOI: 10.3389/fmed.2019.00213] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Van Loon E, Naesens M. Blood transcriptomics as non-invasive marker for kidney transplant rejection. Nephrol Ther 2021;17S:S78-82. [PMID: 33910703 DOI: 10.1016/j.nephro.2020.02.012] [Reference Citation Analysis]
13 O'Huallachain M, Bava FA, Shen M, Dallett C, Paladugu S, Samusik N, Yu S, Hussein R, Hillman GR, Higgins S, Lou M, Trejo A, Qin L, Tai YC, Kinoshita SM, Jager A, Lashkari D, Goltsev Y, Ozturk S, Nolan GP. Ultra-high throughput single-cell analysis of proteins and RNAs by split-pool synthesis. Commun Biol 2020;3:213. [PMID: 32382044 DOI: 10.1038/s42003-020-0896-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jerič Kokelj B, Štalekar M, Vencken S, Dobnik D, Kogovšek P, Stanonik M, Arnol M, Ravnikar M. Feasibility of Droplet Digital PCR Analysis of Plasma Cell-Free DNA From Kidney Transplant Patients. Front Med (Lausanne) 2021;8:748668. [PMID: 34692738 DOI: 10.3389/fmed.2021.748668] [Reference Citation Analysis]
15 Martuszewski A, Paluszkiewicz P, Król M, Banasik M, Kepinska M. Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review. J Clin Med 2021;10:E193. [PMID: 33430458 DOI: 10.3390/jcm10020193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Paul RS, Almokayad I, Collins A, Raj D, Jagadeesan M. Donor-derived Cell-free DNA: Advancing a Novel Assay to New Heights in Renal Transplantation. Transplant Direct 2021;7:e664. [PMID: 33564715 DOI: 10.1097/TXD.0000000000001098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rosenheck JP, Ross DJ, Botros M, Wong A, Sternberg J, Chen Y, Liang N, Baer A, Ahmed E, Swenerton R, Zimmermann BG, Fehringer G, Demko ZP, Olymbios M, Billings PR, Keller BC. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant. Transplantation Direct 2022;8:e1317. [DOI: 10.1097/txd.0000000000001317] [Reference Citation Analysis]
18 Jackson AM, Amato-Menker C, Bettinotti M. Cell-free DNA diagnostics in transplantation utilizing next generation sequencing. Hum Immunol 2021;82:850-8. [PMID: 34600770 DOI: 10.1016/j.humimm.2021.07.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 de Miranda FS, Barauna VG, Dos Santos L, Costa G, Vassallo PF, Campos LCG. Properties and Application of Cell-Free DNA as a Clinical Biomarker. Int J Mol Sci 2021;22:9110. [PMID: 34502023 DOI: 10.3390/ijms22179110] [Reference Citation Analysis]
20 Xiao H, Gao F, Pang Q, Xia Q, Zeng X, Peng J, Fan L, Liu J, Wang Z, Li H. Diagnostic Accuracy of Donor-derived Cell-free DNA in Renal-allograft Rejection: A Meta-analysis. Transplantation 2021;105:1303-10. [PMID: 32890130 DOI: 10.1097/TP.0000000000003443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Thongprayoon C, Hansrivijit P, Leeaphorn N, Acharya P, Torres-Ortiz A, Kaewput W, Kovvuru K, Kanduri SR, Bathini T, Cheungpasitporn W. Recent Advances and Clinical Outcomes of Kidney Transplantation. J Clin Med 2020;9:E1193. [PMID: 32331309 DOI: 10.3390/jcm9041193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Schütz E, Asendorf T, Beck J, Schauerte V, Mettenmeyer N, Shipkova M, Wieland E, Kabakchiev M, Walson PD, Schwenger V, Oellerich M. Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation. Clin Chem 2020;66:1290-9. [PMID: 33001185 DOI: 10.1093/clinchem/hvaa175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
23 Sarwal RD, Yazar W, Titzler N, Wong J, Lai CH, Chin C, Krieger D, Stoll J, Dias Lourenco F, Sarwal MM, Ghosh S. Through the Looking Glass: Unraveling the Stage-Shift of Acute Rejection in Renal Allografts. J Clin Med 2022;11:910. [PMID: 35207183 DOI: 10.3390/jcm11040910] [Reference Citation Analysis]
24 Cheng D, Liu F, Xie K, Zeng C, Li X, Ni X, Ge J, Shu L, Zhou Y, Shi H, Liu H, Chen J. Donor-derived cell-free DNA: An independent biomarker in kidney transplant patients with antibody-mediated rejection. Transpl Immunol 2021;69:101404. [PMID: 33971294 DOI: 10.1016/j.trim.2021.101404] [Reference Citation Analysis]
25 McClure T, Goh SK, Cox D, Muralidharan V, Dobrovic A, Testro AG. Donor-specific cell-free DNA as a biomarker in liver transplantation: A review. World J Transplant 2020; 10(11): 307-319 [PMID: 33312892 DOI: 10.5500/wjt.v10.i11.307] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Dale BL, Bose S, Kuo S, Burns A, Daou P, Short J, Miles J. Transition of Renal Patients Using AlloSure Into Community Kidney Care (TRACK): Protocol for Long-Term Allograft Surveillance in Renal Transplant Recipients. JMIR Res Protoc 2021;10:e25941. [PMID: 33720033 DOI: 10.2196/25941] [Reference Citation Analysis]
27 Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit 2021;43:150-200. [PMID: 33711005 DOI: 10.1097/FTD.0000000000000871] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Andrikovics H, Őrfi Z, Meggyesi N, Bors A, Varga L, Kövy P, Vilimszky Z, Kolics F, Gopcsa L, Reményi P, Tordai A. Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation. Int J Mol Sci 2019;20:E4450. [PMID: 31509957 DOI: 10.3390/ijms20184450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Melancon JK, Khalil A, Lerman MJ. Donor-Derived Cell Free DNA: Is It All the Same? Kidney360 2020;1:1116-21. [DOI: 10.34067/kid.0003512020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
30 Yang JYC, Verleden SE, Zarinsefat A, Vanaudenaerde BM, Vos R, Verleden GM, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Watson D, Sarwal MM. Cell-Free DNA and CXCL10 Derived from Bronchoalveolar Lavage Predict Lung Transplant Survival. J Clin Med 2019;8:E241. [PMID: 30781765 DOI: 10.3390/jcm8020241] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
31 Garg N. Donor-Derived Cell-Free DNA: Is It All the Same? The Jury Is Still Out. Kidney360 2020;1:1036-7. [DOI: 10.34067/kid.0004412020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Kim PJ, Olymbios M, Siu A, Pinzon OW, Adler E, Liang N, Swenerton R, Sternberg J, Kaur N, Ahmed E, Chen Y, Fehringer G, Demko ZP, Billings PR, Stehlik J. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.04.002] [Reference Citation Analysis]
33 Edwards RL, Menteer J, Lestz RM, Baxter-Lowe LA. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches. Biomark Med 2022. [PMID: 35195028 DOI: 10.2217/bmm-2021-0968] [Reference Citation Analysis]
34 Viklicky O, Novotny M, Hruba P. Future developments in kidney transplantation. Curr Opin Organ Transplant 2020;25:92-8. [PMID: 31833964 DOI: 10.1097/MOT.0000000000000722] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
35 Chopra B, Sureshkumar KK. Emerging role of cell-free DNA in kidney transplantation. World J Exp Med 2021; 11(5): 55-65 [PMID: 34877265 DOI: 10.5493/wjem.v11.i5.55] [Reference Citation Analysis]
36 Quaglia M, Merlotti G, Guglielmetti G, Castellano G, Cantaluppi V. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction. Int J Mol Sci 2020;21:E5404. [PMID: 32751357 DOI: 10.3390/ijms21155404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Kaminski MM, Alcantar MA, Lape IT, Greensmith R, Huske AC, Valeri JA, Marty FM, Klämbt V, Azzi J, Akalin E, Riella LV, Collins JJ. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. Nat Biomed Eng 2020;4:601-9. [PMID: 32284553 DOI: 10.1038/s41551-020-0546-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
38 Jaikaransingh V, Kadambi PV. Donor-Derived Cell-Free DNA (ddcf-DNA) and Acute Antibody-Mediated Rejection in Kidney Transplantation. Medicina (Kaunas) 2021;57:436. [PMID: 34062714 DOI: 10.3390/medicina57050436] [Reference Citation Analysis]
39 Herath S, Erlich J, Au AYM, Endre ZH. Advances in Detection of Kidney Transplant Injury. Mol Diagn Ther 2019;23:333-51. [PMID: 30941671 DOI: 10.1007/s40291-019-00396-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Kataria A, Kumar D, Gupta G. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions. Transplantation 2021;105:1203-11. [PMID: 33534526 DOI: 10.1097/TP.0000000000003651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Maldonado AQ, West-Thielke P, Joyal K, Rogers C. Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation. Pharmacotherapy 2021;41:132-43. [PMID: 33156560 DOI: 10.1002/phar.2484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Viklicky O. Are we ready to implement non-invasive tests to detect allograft rejection in a daily praxis? EBioMedicine 2019;41:28-9. [PMID: 30850351 DOI: 10.1016/j.ebiom.2019.03.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Cusick MF, Clark L, Tu T, Goforth J, Zhang X, LaRue B, Gutierrez R, Jindra PT. Performance characteristics of chimerism testing by next generation sequencing. Hum Immunol 2021:S0198-8859(21)00249-4. [PMID: 34728094 DOI: 10.1016/j.humimm.2021.10.004] [Reference Citation Analysis]
44 Seeto RK, Fleming JN, Dholakia S, Dale BL. Understanding and using AlloSure donor derived cell-free DNA. Biophys Rev 2020;12:917-24. [PMID: 32683591 DOI: 10.1007/s12551-020-00713-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Yatim KM, Azzi JR. Novel Biomarkers in Kidney Transplantation. Seminars in Nephrology 2022;42:2-13. [DOI: 10.1016/j.semnephrol.2022.01.007] [Reference Citation Analysis]
46 Puttarajappa CM, Mehta RB, Roberts MS, Smith KJ, Hariharan S. Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers. Am J Transplant 2021;21:186-97. [PMID: 32558153 DOI: 10.1111/ajt.16150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
47 Oellerich M, Shipkova M, Asendorf T, Walson PD, Schauerte V, Mettenmeyer N, Kabakchiev M, Hasche G, Gröne HJ, Friede T, Wieland E, Schwenger V, Schütz E, Beck J. Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study. Am J Transplant 2019;19:3087-99. [PMID: 31062511 DOI: 10.1111/ajt.15416] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 24.0] [Reference Citation Analysis]
48 Kant S, Brennan DC. Donor-Derived Cell-Free DNA in Kidney Transplantation: Origins, Present and a Look to the Future. Medicina (Kaunas) 2021;57:482. [PMID: 34065914 DOI: 10.3390/medicina57050482] [Reference Citation Analysis]
49 Zhang H, Zheng C, Li X, Fu Q, Li J, Su Q, Zeng L, Liu Z, Wang J, Huang H, Xu B, Ye M, Liu L, Wang C. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study. Front Immunol 2020;11:342. [PMID: 32184785 DOI: 10.3389/fimmu.2020.00342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
50 Bronkhorst AJ, Ungerer V, Diehl F, Anker P, Dor Y, Fleischhacker M, Gahan PB, Hui L, Holdenrieder S, Thierry AR. Towards systematic nomenclature for cell-free DNA. Hum Genet 2021;140:565-78. [PMID: 33123832 DOI: 10.1007/s00439-020-02227-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Watson D, Yang JYC, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Louie V, Sigdel S, Livingstone D, Soh K, Chakraborty A, Liang M, Lin PC, Sarwal MM. A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury. J Clin Med 2019;8:E499. [PMID: 31013714 DOI: 10.3390/jcm8040499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
52 Thongprayoon C, Vaitla P, Craici IM, Leeaphorn N, Hansrivijit P, Salim SA, Bathini T, Rivera FHC, Cheungpasitporn W. The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status. J Clin Med 2020;9:E1480. [PMID: 32423115 DOI: 10.3390/jcm9051480] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
53 Stawski R, Stec-Martyna E, Chmielecki A, Nowak D, Perdas E. Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical Trials. Biology (Basel) 2021;10:906. [PMID: 34571783 DOI: 10.3390/biology10090906] [Reference Citation Analysis]
54 Halloran PF, Reeve J, Madill-thomsen KS, Demko Z, Prewett A, Billings P; the Trifecta Investigators*. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies. JASN. [DOI: 10.1681/asn.2021091191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
55 Williams MD, Fei M, Schadde E, Hollinger EF, Chan EY, Olaitan O. Early Experience Using Donor-derived Cell-free DNA for Surveillance of Rejection Following Simultaneous Pancreas and Kidney Transplantation. Transplantation Direct 2022;8:e1321. [DOI: 10.1097/txd.0000000000001321] [Reference Citation Analysis]
56 Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM. A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection. Sci Transl Med. 2020;12. [PMID: 32188722 DOI: 10.1126/scitranslmed.aba2501] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
57 Puttarajappa CM, Mehta RB, Hariharan S. Donor-derived Cell-free DNA for the Diagnosis of Kidney Transplant Rejection: An Attractive Test With Ambiguous Answers! Transplantation 2021;105:1171-2. [PMID: 33606484 DOI: 10.1097/TP.0000000000003696] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Oellerich M, Christenson RH, Beck J, Schütz E, Sherwood K, Price CP, Keown PA, Walson PD. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition. J Appl Lab Med 2020;5:993-1004. [PMID: 32447378 DOI: 10.1093/jalm/jfaa062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
59 Di W, Ran Q, Yang H, Lu J, Hou Y, Wang X, He J, Wei L. Use of graft-derived cell-free DNA as a novel biomarker to predict allograft function after kidney transplantation. Int J Urol 2021. [PMID: 34229363 DOI: 10.1111/iju.14638] [Reference Citation Analysis]
60 Bloom RD, Augustine JJ. Beyond the Biopsy: Monitoring Immune Status in Kidney Recipients. Clin J Am Soc Nephrol 2021:CJN. [PMID: 34362810 DOI: 10.2215/CJN.14840920] [Reference Citation Analysis]
61 Lum EL, Nieves-borrero K, Homkrailas P, Lee S, Danovitch G, Bunnapradist S. Title: Single center experience comparing two clinically available donor derived cell free DNA tests and review of literature. Transplantation Reports 2021;6:100079. [DOI: 10.1016/j.tpr.2021.100079] [Reference Citation Analysis]
62 Park S, Guo K, Heilman RL, Poggio ED, Taber DJ, Marsh CL, Kurian SM, Kleiboeker S, Weems J, Holman J, Zhao L, Sinha R, Brietigam S, Rebello C, Abecassis MM, Friedewald JJ. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients. Clin J Am Soc Nephrol 2021;16:1539-51. [PMID: 34620649 DOI: 10.2215/CJN.05530421] [Reference Citation Analysis]
63 Wijtvliet VPWM, Plaeke P, Abrams S, Hens N, Gielis EM, Hellemans R, Massart A, Hesselink DA, De Winter BY, Abramowicz D, Ledeganck KJ. Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis. Transpl Int 2020;33:1626-42. [PMID: 32981117 DOI: 10.1111/tri.13753] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
64 Bunnapradist S, Tabriziani H. Authors' Reply. J Am Soc Nephrol 2021;32:2973-4. [PMID: 34716246 DOI: 10.1681/ASN.2021081039] [Reference Citation Analysis]
65 Kurian S, Friedewald J. Comparing Plasma Donor-Derived Cell-free DNA to Indication Kidney Biopsy Tissue Gene Expression: Toward Understanding the Molecular Equivalents of Non-Invasive Tests. JASN. [DOI: 10.1681/asn.2021121595] [Reference Citation Analysis]
66 Nolan N, Valdivieso K, Mani R, Yang JYC, Sarwal RD, Katzenbach P, Chalasani K, Hongo D, Lugtu G, Mark C, Chen E, Nijor R, Savoca D, Wexler DS, Whitson T, Huang SJ, Lu LH, Zawada RJX, Hytopoulos E, Sarwal MM. Clinical and Analytical Validation of a Novel Urine-Based Test for the Detection of Allograft Rejection in Renal Transplant Patients. J Clin Med 2020;9:E2325. [PMID: 32707779 DOI: 10.3390/jcm9082325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
67 Bunnapradist S, Datta N, Schaenman J, Ioannou N, Bloom MS, Malhotra M, Tabriziani H, Gauthier P, Ahmed E, Billings PR, Lum EL. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection. Transplant Direct 2021;7:e691. [PMID: 33912658 DOI: 10.1097/TXD.0000000000001145] [Reference Citation Analysis]
68 Grskovic M, Hiller D, Woodward RN. Performance of Donor-derived Cell-free DNA Assays in Kidney Transplant Patients. Transplantation 2020;104:e135. [PMID: 32044893 DOI: 10.1097/TP.0000000000003084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
69 Levitsky J, Kandpal M, Guo K, Kleiboeker S, Sinha R, Abecassis M. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant 2021. [PMID: 34510731 DOI: 10.1111/ajt.16835] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
70 Filippone EJ, Farber JL. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation. Transplantation 2021;105:509-16. [PMID: 32732615 DOI: 10.1097/TP.0000000000003393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
71 Dengu F. Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation. Transplant Rev (Orlando). 2020;34:100542. [PMID: 32265093 DOI: 10.1016/j.trre.2020.100542] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
72 Bloom RD. Using (cell-free) DNA to incriminate rejection as the cause of kidney allograft dysfunction: Do we have a verdict? Am J Transplant 2019;19:1609-10. [PMID: 30835968 DOI: 10.1111/ajt.15338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]